Cosmos Holdings, Inc., through its wholly owned subsidiary Sky Pharm S.A., offers a first look at its Sky Premium Life® Brand of food supplements. CHICAGO, IL- - April 19, 2018 - Cosmos Holdings, Inc. (OTCQB: COSM), released the design and packaging of its first set of dietary supplements. These premium supplements boast a sleek design and packaging along with best in class formulation. The line of more than 60 products is based on ...

CHICAGO, April 20, 2018 - Cosmos Holdings, Inc. (Cosmos) (COSM), an international pharmaceutical company, announced today its full-year 2017 financial results for the year ended December 31, 2017. Full-year 2017 revenue increased 347% to $30.0 million from $6.7 million in 2016, fueled by strong execution on customer network expansion and by securing approximately $10.2 million in additional capital. Cosmos also achieved gross profit growth of 225% in 2017, an increase to $1.95 million in 2017 from ...

CHICAGO, IL March 21, 2018 - COSMOS HOLDINGS INC. (COSM) (“Company”) is pleased to announce that it has signed a definitive agreement with Marathon Global Inc. to source and procure medical cannabis products and their derivatives for clients of Cosmos in approved Countries in Cosmos’ distribution network of approximately 35,000 pharmacies across Europe. “Marathon Global is superbly positioned within the global Cannabis industry and views the underserviced European market as a tremendous opportunity,” says Gavin Treanor, Marathon ...

CHICAGO, IL- - November 16th, 2017 - Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that it has entered into a $3 million securities purchase agreement with two institutional investors. “We are excited to announce the addition of two institutional investors,” said Grigorios Siokas, President and CEO of Cosmos Holdings. “This agreement will provide us with capital to continue to grow our operations and expand our business.” The securities sold have ...

Revenue Improved 575% and Gross Profit Improved 434% compared to the three months ended September 30, 2016 CHICAGO, IL- - November 20, 2017 - Cosmos Holdings, Inc. ("the Company") (OTCQB: COSMD & COSM), an international pharmaceutical company, announced financial results for the quarter ended September 30, 2017. Highlights: Quarter ended September 30, 2017, versus the quarter ended September 30, 2016, revenue improved 575% to $9.5 million from $1.4 million. Revenue improved sequentially 56%, from $6.1 million in the 2017 ...